JPMorgan Chase & Co. Sells 10,273,049 Shares of SPDR S&P Biotech ETF $XBI

JPMorgan Chase & Co. decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 75.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 3,265,689 shares of the exchange traded fund’s stock after selling 10,273,049 shares during the quarter. JPMorgan Chase & Co.’s holdings in SPDR S&P Biotech ETF were worth $398,186,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in XBI. Assetmark Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 1,042,265.6% in the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after purchasing an additional 635,782 shares during the last quarter. Greenwoods Asset Management Hong Kong Ltd. bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $55,613,000. Ameriprise Financial Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 123.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares during the last quarter. Main Street Research LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $43,959,000. Finally, Marks Wealth LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $28,857,000.

SPDR S&P Biotech ETF Stock Down 1.9%

Shares of NYSEARCA XBI opened at $128.85 on Thursday. The firm’s 50-day simple moving average is $132.43 and its 200 day simple moving average is $126.96. The company has a market cap of $8.22 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 12-month low of $80.90 and a 12-month high of $139.19.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.